Zürcher Kantonalbank is a Swiss commercial bank established in 1870 and headquartered in Zurich. It operates as an independent public-law institution, wholly owned by the canton of Zurich, and adheres to a public service mandate that encompasses economic, social, and environmental commitments. The bank provides a variety of financial services, including savings and investment accounts, mortgage loans, investment management, and professional financing advisory services, primarily for Swiss and German clients. Additionally, Zürcher Kantonalbank offers international banking services such as international payments, letters of credit, export financing, and bank guarantees. It also caters to institutional, professional, and private investors with a range of investment solutions and advisory services.
Annaida Technologies SA, founded in 2019 and based in Lausanne, Switzerland, specializes in the development of EmbryoSpin, an innovative device designed for biochemical research. This device performs microscopic nuclear magnetic resonance (µNMR) with a sensitivity that surpasses existing technologies by tenfold, allowing for chemical analysis at the scale of a single human embryo. EmbryoSpin is engineered for robustness and user-friendliness, making it suitable for non-invasive embryo viability screening in in-vitro fertilization and various biochemical studies. The company's advancements aim to enhance medical research capabilities, particularly in the context of reproductive health.
DePoly
Seed Round in 2025
DePoly is a chemical recycling company focused on addressing the challenges posed by plastic waste. Its innovative technology converts post-consumer PET plastic and polyester textiles into their primary raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This process enables the production of high-quality raw materials that can be reintegrated into the industry, facilitating the creation of new virgin-quality plastic products. By promoting this method, DePoly aims to contribute to a circular plastic economy, supporting sustainability and reducing environmental impact.
AICA SA
Seed Round in 2025
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
Dphi Space
Pre Seed Round in 2025
DPhi Space is focused on creating ridesharing platforms to make space access more democratic and affordable. The company aims to streamline the deployment of small satellites by integrating multiple payloads and coordinating launch schedules with various providers. This approach reduces the costs and complexities typically associated with satellite launches, allowing researchers to optimize capacity utilization and decrease dependency on dedicated launches. As a result, DPhi Space facilitates faster and more cost-effective deployment of both software and hardware in orbit, contributing to the advancement of spacefaring infrastructure.
Eleven Dynamics
Seed Round in 2025
Eleven Dynamics specializes in software technology aimed at automating quality control processes across various industries. The company's software solutions facilitate the design and simulation of customized quality processes, enabling users to automatically program measurement paths efficiently without requiring expertise in robotics. By connecting all hardware in real time, the technology streamlines the execution of measurement processes, making it accessible for businesses seeking to enhance their operational efficiency. Eleven Dynamics focuses on creating tailored robotic solutions that address the specific needs of its clients.
Grand Resort Bad Ragaz
Debt Financing in 2024
Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.
embotech
Series B in 2024
embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.
Retinai
Series B in 2024
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Somagenetix
Series A in 2024
Somagenetix is a biotechnology company focused on developing innovative gene therapies for phagocyte-related illnesses, particularly targeting severe inherited immune diseases, immunodeficiency, neurodegeneration, and cancer with brain metastases. The company specializes in discovering and developing stem cells from bone marrow and utilizing lentiviral vectors to deliver therapeutic genes. This approach aims to correct the underlying genetic defects in patients by transplanting gene-corrected cells back into the body, ultimately providing a potential cure for various monogenic disorders. With a commitment to advancing the field of gene therapy, Somagenetix aims to lead in creating first-in-class treatments that address significant medical needs.
Lymphatica Medtech
Series B in 2024
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.
AskEarth
Seed Round in 2024
AskEarth is a geospatial intelligence platform that delivers real-time and accurate geospatial information to help users predict future environmental changes. Originating as a spin-off from the University of Zurich, ETH, and EPFL, AskEarth specializes in providing unique insights derived from daily satellite images. Its platform includes features that comply with the EU Deforestation Regulation, offering tools for exposure assessment, automatic deforestation monitoring, and reporting. Users can monitor various environmental phenomena, such as coastline changes, deforestation, glacier melting, and transportation patterns. Additionally, the platform serves as an accessible resource for verifying news articles and obtaining essential earth observation data, enabling clients to explore and understand the planet effortlessly.
Isochronic
Seed Round in 2024
Isochronic specializes in the manufacture of industrial robotic products designed for pick and place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thereby enhancing the efficiency of high-volume production lines. By enabling industries to automate their processes, Isochronic aims to increase productivity while conserving valuable factory floor space. Its innovative approach to pick-and-place technology positions the company as a key player in the automation sector, addressing the growing demand for advanced manufacturing solutions.
Calingo
Seed Round in 2024
Calingo is a digital insurance platform that specializes in providing personalized insurance coverage at the point of sale. The company focuses on delivering customized insurance products designed to meet individual needs, ensuring transparency and tailored options for customers. By optimizing risk protection, Calingo enables users to access suitable insurance solutions at fair prices, enhancing the overall purchasing experience.
Complementa
Acquisition in 2024
Complementa is a Swiss firm based in Saint Gallen, founded in 1984, that specializes in providing consolidated performance reporting, accounting, investment consulting, and investment control services. The firm assists investors by planning, designing, and monitoring their investment and financing processes, ensuring that they have the necessary support to make informed decisions.
Drone Harmony
Venture Round in 2024
Drone Harmony, founded in 2016, specializes in developing a data-driven mission planning platform for drones, aimed at enhancing the efficiency of industrial inspections. The company's innovative 3D flight planning software transforms users into inspection professionals by utilizing advanced algorithms to automate complex tasks. This approach allows for scalable workflows, facilitating the transition from small proof-of-concept projects to large-scale enterprise operations. By addressing the mathematical and engineering challenges associated with drone deployment, Drone Harmony enables clients to adopt drone technology effectively across various industries, promoting process automation and increasing operational efficiency.
Synthara
Venture Round in 2024
Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.
Microcaps
Series A in 2024
Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.
DataHow
Series A in 2024
DataHow AG is a spin-off from ETH Zurich that specializes in data analytics and process modeling tailored for the biopharmaceutical and chemical industries. The company offers digital solutions and consulting services aimed at process monitoring, optimization, and scale-up. By focusing on improving the understanding of complex manufacturing processes, DataHow helps clients reduce effort, risks, and costs associated with process development and manufacturing. Through its technological expertise, the company enables clients to enhance their operational efficiency and ensure more effective management of their production processes.
Retinai
Series A in 2024
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Testmate Health
Seed Round in 2024
Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.
Bcomp
Series C in 2024
Bcomp Ltd. is a manufacturer based in Fribourg, Switzerland, specializing in natural fiber composites. Founded in 2003, the company produces innovative products such as ampliTex, a natural flax fiber available in various forms, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies, developed from years of research and patented innovations, allow for the creation of structural components that can effectively replace traditional materials like aluminum and carbon fiber. The company serves diverse industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure, focusing on enhancing efficiency in weight, rigidity, shock absorption, and damping. Bcomp collaborates closely with its customers to tailor solutions that meet specific needs while continuing to strengthen its research and development efforts through academic partnerships.
progile
Seed Round in 2024
Autonomous Testing with Zero Flakiness. The TrueTest Technology and our AI-based virtual user makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. We simplified automated testing massively and reduced time radically. With it, the automation and maintenance effort is reduced to a minimum: zero flakiness and the enlightening feeling of being in control of your automation and test scenarios. It's not about buzzwords and being one of the cool kids. Our mission was to solve the daily problems of test automation. And that's what we did. OUR TECHNOLOGY Stop losing your time on tasks automation should have eliminated The power of TestResults.io lies in its core, the TrueTest technology. It includes Visual Matching, Visual Sense, and Codified Expertise. Visual Matching Identifies elements in a technology-agnostic way through image convolution, text detection, and our unique ReverseOCR Visual Sense Identifies interaction position without hints to solve flakiness with spatial algorithms and automatic candidate selection. It doesn’t matter if the label is outside or inside, above, left from the field or anywhere else. It doesn’t matter if the position changes in a responsive layout. Visual Sense, always knows what label is related to which field. Codified Expertise Knows how to interact with elements through autonomous interactions and automatic verification.
Hemotune
Series B in 2024
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Odne
Series A in 2024
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Cultivated Biosciences
Seed Round in 2024
Cultivated Biosciences is a food production company focused on developing specialized fat ingredients derived from oleaginous yeast. This innovative approach aims to enhance the creaminess and mouthfeel of plant-based dairy products, such as cheese and yogurt, making them more appealing to consumers. The company's yeast-based ingredients provide a clean label and sustainable production process, mimicking the texture and color of traditional dairy while featuring properties like low lipid oxidation and natural emulsification. This enables the production of healthier, animal-free alternatives that cater to the growing demand for plant-based options.
Food Brewer
Seed Round in 2024
Food Brewer AG is a Switzerland-based company specializing in the development of food and food ingredients through innovative plant cell culture technologies. By utilizing large-scale cultivation methods akin to beer brewing, Food Brewer offers alternatives to conventional agriculture, thereby addressing challenges related to geographic, climatic, and ethical uncertainties in food production. The company focuses on creating sustainable ingredients, including cocoa, coffee, nuts, and grains, which cater to the needs of the food industry. Through its research and development efforts, Food Brewer aims to provide clients with reliable and resource-efficient options for food sourcing.
Artiria Medical
Series A in 2024
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.
QUMEA
Series A in 2024
Qumea specializes in medical technology focused on discreet patient monitoring and fall prevention in healthcare settings. By integrating artificial intelligence with advanced 3D radar technology, Qumea offers a comprehensive solution that enhances patient safety while reducing the workload of caregivers. The company's system comprises a 3D radar sensor, cloud infrastructure, and a user-friendly application, creating an efficient early-warning mechanism that aids in effective mobility monitoring. This innovative approach not only enhances care quality but also leads to significant cost savings for hospitals and care institutions.
BTRY
Pre Seed Round in 2024
BTRY, a spin-off from EMPA and ETH, specializes in the development of the first energy-dense solid-state battery, leveraging advanced semiconductor manufacturing techniques. The company aims to provide a sustainable energy storage solution, offering customizable battery properties to cater to diverse customer needs. By eliminating the need for solvent evaporation and recycling, BTRY's technology enables businesses and consumers to reduce energy consumption.
ENANTIOS
Venture Round in 2024
Scientific Instrumentation and Services
Gerald Group
Debt Financing in 2024
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
Aesyra
Seed Round in 2023
Aesyra SA, founded in 2017 and based in Lausanne, Switzerland, specializes in the design and manufacture of medical devices focused on managing sleep disorders. The company's flagship product, AesyBite, is an intra-oral sensor that monitors and alleviates sleep bruxism, a condition characterized by teeth grinding during sleep. Aesyra's technology enables dental professionals to conduct intraoral measurements while patients sleep, allowing for the detection of bruxism and other sleep-related issues, such as obstructive sleep apnea. By providing accurate monitoring and biofeedback alternatives, Aesyra aims to help healthcare providers reduce damage to dental prostheses caused by occlusal problems and improve overall sleep quality for their patients.
Onena Medicines
Venture Round in 2023
Onena Medicines is a biotechnology company focused on developing innovative biological therapies to meet the significant clinical needs of breast cancer and other serious orphan diseases. The company utilizes a proprietary antibody drug discovery platform that leverages artificial intelligence to create custom antibodies with high selectivity and specificity. This platform is designed to reprogram cancer cells and modulate the activities of a novel set of growth factors known as dual smad inhibiting protein dips, which are believed to contribute to cancer growth and metastasis. By doing so, Onena Medicines aims to provide physicians with access to new treatment options in areas where there is a lack of effective therapies.
Helio
Debt Financing in 2023
Helio provides a cloud-based platform that optimizes workload execution while minimizing carbon emissions. By utilizing containerized workloads and cloud-native principles, Helio effectively matches computing demands with available resources, allowing companies to carry out large-scale tasks such as 3D rendering and machine learning. The platform is designed with security features to facilitate safe interactions between users and the system. Helio's focus on carbon awareness aims to address the significant energy consumption of data centers, making it easier for businesses to operate sustainably while achieving cost-effective and scalable computing solutions.
Nagi Bioscience
Series A in 2023
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.
Tune Insight
Seed Round in 2023
Tune Insight specializes in data security software that enables secure collaborations on sensitive data among multiple organizations. The company's innovative platform employs advanced analytics, privacy measures, and encryption technologies to facilitate federated learning, allowing organizations to collaboratively extract insights while maintaining control over their data. By fostering a secure environment for data sharing, Tune Insight helps organizations make informed decisions together, leveraging collective intelligence without compromising data privacy.
Hylomorph
Series B in 2023
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.
Nezasa
Venture Round in 2023
Nezasa is a travel technology company that provides a comprehensive booking solution designed to enhance the travel planning experience for brands worldwide. Its platform enables the integration of various travel services into a single, user-friendly interface, allowing for the seamless planning and booking of multi-product or multi-stop itineraries. Nezasa's offerings include TripBuilder, which facilitates real-time planning and hyper-personalized packaging of trips, and TripBooster, which enhances in-destination upselling opportunities. The company’s technology combines the efficiency of online portals with the personalized touch of traditional travel agencies, allowing tour operators and travel retailers to automate and customize their travel offerings. By leveraging standardized and customizable APIs within a secure cloud-based environment, Nezasa supports the immediate booking of tailored trips, making it a valuable partner for travel brands seeking to optimize their customer experience.
DePoly
Seed Round in 2023
DePoly is a chemical recycling company focused on addressing the challenges posed by plastic waste. Its innovative technology converts post-consumer PET plastic and polyester textiles into their primary raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This process enables the production of high-quality raw materials that can be reintegrated into the industry, facilitating the creation of new virgin-quality plastic products. By promoting this method, DePoly aims to contribute to a circular plastic economy, supporting sustainability and reducing environmental impact.
Distran
Series B in 2023
Distran, a spin-off from the Autonomous System Lab at ETH Zurich, specializes in the development of advanced acoustic sensors aimed at enhancing safety for industrial workers and minimizing environmental impact. The company focuses on manufacturing ultrasound cameras that cater to various sectors, including oil and gas, power generation, and chemical engineering. Distran's innovative phased-array sensors address the limitations of traditional acoustic sensors, which often struggle to function effectively in noisy industrial environments. By spatially filtering sounds, these sensors enable the detection of defects such as leaks or discharges from a safe distance, thereby allowing clients to protect their workforce and reduce their ecological footprint.
UniSieve
Seed Round in 2023
UniSieve Ltd, founded in 2018 and headquartered in Zurich, Switzerland, develops and manufactures advanced molecular sieving membranes that enable efficient separation solutions across various industries. The company's innovative platform technology integrates molecular sieves with polymeric membranes to facilitate applications such as chemical feedstock purification, biogas upgrading, gas and liquid separation, and specialized uses in sensing and space-related projects. UniSieve's technology is designed to enhance energy efficiency in size-based purification processes, supporting clients in reducing carbon dioxide emissions, improving recycling rates, and lowering operational costs.
Nexoya
Series A in 2023
Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.
Gerald Group
Debt Financing in 2023
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
tado°
Venture Round in 2023
tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.
Correntics
Pre Seed Round in 2023
Correntics operates a climate risk assessment platform aimed at enhancing the resilience of global supply chains. By employing a data-driven approach, the company provides clients with a comprehensive overview of their supply chains, from raw material availability to final delivery. Its platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling clients to gain actionable insights that help mitigate potential disruptions. Correntics' expertise supports businesses in reducing risks associated with climate change and other emerging threats, ultimately fostering improved operational efficiency and financial stability while ensuring sustainability in their activities.
Medyria
Series B in 2023
Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.
Resistell
Series B in 2022
Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.
Insolight
Venture Round in 2022
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of high-efficiency solar panels. The company has achieved significant advancements in solar technology, with modules reaching a record efficiency of 29 percent, which allows for a reduction in residential solar electricity costs to below 0.1 $/kWh. Insolight's innovative optical technology enhances efficiency while maintaining the simplicity of installation comparable to standard flat panels. The company's solar systems also incorporate an integrated tracking method to optimize energy capture, maximizing solar utility for agricultural applications. Insolight's business model focuses on developing intellectual property, overseeing wholesale distribution, and outsourcing manufacturing, ensuring a streamlined approach to delivering cost-effective solar solutions. The technology has been validated by reputable institutions, demonstrating its potential for widespread impact in both residential and agricultural sectors.
TerraRad Tech
Convertible Note in 2022
TerraRad Tech specializes in the development and marketing of remote sensing devices designed to optimize agricultural efficiency and sustainability. The company offers drone and vehicle-mounted sensors that measure soil moisture and crop water content, providing actionable data that helps reduce water usage in farming. Their turfRad line specifically targets golf courses, utilizing a SaaS model combined with sensor hardware to achieve significant irrigation water savings. By developing advanced microwave radiometers for both UAV-based and ground-based systems, TerraRad Tech aims to enhance soil moisture measurement capabilities, ultimately supporting more efficient agricultural practices.
Navignostics
Seed Round in 2022
Navignostics is focused on improving cancer treatment by using spatial single-cell proteomics to characterize tumors. The company aims to identify the most effective therapies for individual patients, thereby enhancing personalized diagnostics and reducing patient suffering. In addition to tailoring treatments, Navignostics accelerates cancer drug development by offering critical insights into drug mechanisms and tumor characteristics, which are essential for companion diagnostic development. This approach not only enables clinicians to make informed treatment recommendations but also increases the availability of effective drugs for cancer patients. By leveraging its advanced technology and data analytics, Navignostics provides valuable services to pharmaceutical and biotech partners, ultimately contributing to better outcomes for those affected by cancer.
vestr
Venture Round in 2022
Vestr is a technology company that specializes in providing a software-as-a-service platform designed for the creation and management of actively managed investment products. Its end-to-end solution addresses the complexities of active management by digitizing the entire value chain, allowing issuers and portfolio managers to concentrate on their core activities. The platform includes tools for portfolio management, order execution, and performance reporting, enabling clients to efficiently manage their investments, make informed decisions, and mitigate risks. By streamlining processes such as portfolio rebalancing and investor reporting, Vestr enhances operational efficiency without directly issuing its own structured products.
Avelo
Seed Round in 2022
Avelo is a manufacturer of diagnostic equipment focused on infectious diseases. The company has developed a non-invasive breath aerosol testing system that allows for rapid detection of multiple lower respiratory tract infections. This innovative product enables primary care providers to conduct quick sample-to-answer tests, providing results within minutes through a streamlined three-step process. By facilitating early diagnosis, Avelo's technology aims to improve patient outcomes through timely antibiotic or antiviral treatment and efficient patient referrals. The company's mission centers on enhancing the speed and accuracy of infectious disease diagnoses to ultimately save lives.
Skribble
Series A in 2022
Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.
Piomic Medical
Series A in 2022
Piomic is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly in patients with hard-to-heal leg and foot ulcers. The company's flagship product, the COMS® One Therapy System, is a portable, hand-held device that uses optical and magnetic stimulation technologies to promote wound healing. Clinical studies demonstrate that this device is safe and effective, leading to accelerated wound closure, reduced pain, and improved quality of life for patients. Designed for ease of use, the device features a single-button operation and can be utilized in various settings, including stationary and ambulatory facilities, as well as in patients’ homes. By focusing on a therapy that provides significant benefits, Piomic seeks to improve the treatment outcomes for individuals suffering from chronic wounds and alleviate the cost burden on healthcare systems.
Pipra
Seed Round in 2022
Pipra is a MedTech start-up focused on addressing the significant issue of delirium in healthcare, particularly Post-Operative Delirium (POD), which affects around 20% of patients over 60 and incurs substantial costs for hospitals and insurers. The company has developed an AI-driven clinical decision support software that enables healthcare professionals to identify high-risk patients prior to surgery. This pre-operative risk assessment tool utilizes standard medical data and can be accessed via web or app, providing a score-based risk assessment in under two minutes. By highlighting patients at risk, Pipra's solution allows for the implementation of targeted interventions that have been shown to reduce the incidence of POD by 53%. Currently, Pipra's technology is operational in three hospitals, with plans for deployment in an additional 22 hospitals across Europe. The company's advisory board includes experts from renowned institutions such as Johns Hopkins, Harvard, and Cornell, further enhancing its credibility in the field.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Smeetz
Series A in 2022
Smeetz SA is an online booking platform based in Lausanne, Switzerland, that specializes in the leisure and entertainment industry. Founded in 2016, the company offers a comprehensive suite of solutions designed to streamline event organization and promotion. Its platform incorporates AI-powered tools for sales, marketing, reservation management, ticket booking, and distribution. Smeetz employs dynamic pricing strategies and data analytics to help venues optimize revenue and enhance operational efficiency. The platform also includes features such as a booking widget, cross-channel sales, access control, payment methods, and customizable ticket solutions. By unifying commerce and embedding financial tools, Smeetz aims to transform the customer experience in the leisure sector, enabling businesses to thrive in a competitive environment.
Odne
Seed Round in 2022
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Isochronic
Seed Round in 2022
Isochronic specializes in the manufacture of industrial robotic products designed for pick and place applications. The company focuses on developing next-generation robots that can transport multiple parts simultaneously, thereby enhancing the efficiency of high-volume production lines. By enabling industries to automate their processes, Isochronic aims to increase productivity while conserving valuable factory floor space. Its innovative approach to pick-and-place technology positions the company as a key player in the automation sector, addressing the growing demand for advanced manufacturing solutions.
Hemotune
Series B in 2022
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Sleepiz
Series A in 2022
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
9T Labs
Series A in 2022
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.
Odne
Seed Round in 2022
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Drone Harmony
Seed Round in 2022
Drone Harmony, founded in 2016, specializes in developing a data-driven mission planning platform for drones, aimed at enhancing the efficiency of industrial inspections. The company's innovative 3D flight planning software transforms users into inspection professionals by utilizing advanced algorithms to automate complex tasks. This approach allows for scalable workflows, facilitating the transition from small proof-of-concept projects to large-scale enterprise operations. By addressing the mathematical and engineering challenges associated with drone deployment, Drone Harmony enables clients to adopt drone technology effectively across various industries, promoting process automation and increasing operational efficiency.
Nanoleq
Series A in 2021
Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.
Hylomorph
Series B in 2021
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.
xorlab
Series A in 2021
xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.
Seervision
Funding Round in 2021
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.
Scewo
Series A in 2021
Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in designing and manufacturing innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that integrates both wheels and tracks, allowing for enhanced maneuverability over various terrains, including curbs, tram tracks, grass, and uneven surfaces. This self-balancing wheelchair features an active control system that maintains stability and levelness, enabling users to navigate obstacles with ease. Users can control the chair through a joystick or by shifting their body weight, providing a versatile solution to improve mobility and independence for those with disabilities.
Sleepiz
Series A in 2021
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
RoomPriceGenie
Seed Round in 2021
RoomPriceGenie AG, founded in 2017 and headquartered in Steinhausen, Switzerland, specializes in developing revenue management software for hotels, apartments, and vacation rentals. The platform employs advanced dynamic pricing algorithms and real-time analytics to optimize room pricing based on market demand and occupancy levels. It offers features such as automated pricing adjustments, manual control options, and seamless integration with various property management systems and channel managers. This allows users to update all prices with a single click, enhancing operational efficiency. RoomPriceGenie is designed for small to medium-sized hotels, providing a user-friendly interface and excellent customer support to help clients boost their revenue effectively.
Eldico Scientific
Seed Round in 2021
Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.
Qnami
Series A in 2021
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Nexoya
Seed Round in 2021
Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.
Futurae
Venture Round in 2021
Futurae, established in 2016 as a spin-off from ETH Zurich, specializes in enhancing the authentication process for users and businesses. The company provides a comprehensive Authentication Platform that incorporates AI-driven solutions and adheres to regulatory standards, such as PSD2 and SCA. Futurae's offerings aim to reduce user friction and improve the overall user experience while simultaneously lowering support costs for organizations. Serving over 130 clients, including banks, insurance companies, online retailers, and digital wallets, Futurae enables real-time fraud detection and facilitates seamless user journeys with adaptive online security measures.
Apiax
Venture Round in 2021
Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.
Microcaps
Seed Round in 2021
Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.
Synendos Therapeutics
Series A in 2020
Synendos Therapeutics AG is a biopharmaceutical company based in Allschwil, Switzerland, founded in 2019. The company focuses on developing innovative therapies for unmet needs in neuropsychiatric disorders, particularly anxiety, mood, and stress-related conditions. Synendos utilizes a novel drug target within the endocannabinoid system to restore the brain's natural functioning. Its therapies involve the modulation of cannabinoid activity and the inhibition of endocannabinoid transport across cell membranes, addressing altered neurotransmission in various brain regions. This approach presents a promising solution to the significant demand for effective pharmacological treatments, especially for conditions like post-traumatic stress disorder (PTSD), which currently lacks adequate therapeutic options.
Voliro
Seed Round in 2020
Voliro is a pioneer in mobile robotics, specializing in innovative solutions for work at heights through advanced flying robots. These robots are designed for contact-based tasks, leveraging a proprietary tiltable rotor system that transforms conventional drones into versatile robotic platforms capable of precise environmental interaction. Their unique 360° drone design enables inspections on curved and sloped surfaces, setting them apart in the market. Voliro's aerial robots can be equipped with various payloads, including Non-Destructive Testing (NDT) sensors and Lightning Protection System (LPS) sensors, to enhance the efficiency and reliability of inspections. The company focuses on delivering automated nondestructive testing inspections, ultrasonic thickness measurements, and thermal imaging, allowing clients to achieve asset inspection and monitoring services that are safer, faster, and more cost-effective.
Hemotune
Series A in 2020
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Insolight
Series A in 2020
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of high-efficiency solar panels. The company has achieved significant advancements in solar technology, with modules reaching a record efficiency of 29 percent, which allows for a reduction in residential solar electricity costs to below 0.1 $/kWh. Insolight's innovative optical technology enhances efficiency while maintaining the simplicity of installation comparable to standard flat panels. The company's solar systems also incorporate an integrated tracking method to optimize energy capture, maximizing solar utility for agricultural applications. Insolight's business model focuses on developing intellectual property, overseeing wholesale distribution, and outsourcing manufacturing, ensuring a streamlined approach to delivering cost-effective solar solutions. The technology has been validated by reputable institutions, demonstrating its potential for widespread impact in both residential and agricultural sectors.
vestr
Series A in 2020
Vestr is a technology company that specializes in providing a software-as-a-service platform designed for the creation and management of actively managed investment products. Its end-to-end solution addresses the complexities of active management by digitizing the entire value chain, allowing issuers and portfolio managers to concentrate on their core activities. The platform includes tools for portfolio management, order execution, and performance reporting, enabling clients to efficiently manage their investments, make informed decisions, and mitigate risks. By streamlining processes such as portfolio rebalancing and investor reporting, Vestr enhances operational efficiency without directly issuing its own structured products.
Artiria Medical
Series A in 2020
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.
Metaco
Series A in 2020
Metaco is a Swiss company that specializes in providing institutional digital asset management solutions. It offers a comprehensive orchestration platform designed for financial institutions to issue, secure, manage, and trade digital assets. Metaco's platform supports the entire lifecycle of asset tokens, including the management of cryptocurrencies, tokens, and smart contracts. By utilizing advanced blockchain technologies, the company ensures a secure and efficient environment for digital asset management. Additionally, Metaco's solutions incorporate risk management to balance asset security and liquidity, allowing institutions to connect with over 50 exchanges, brokers, and market makers, thereby facilitating seamless trading across various asset classes such as equities, bonds, and derivatives.
Positrigo
Series A in 2020
Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.
xorlab
Seed Round in 2020
xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.
Skribble
Series B in 2020
Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.
PXL Vision
Seed Round in 2020
PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.
Livet
Seed Round in 2020
Livet designs and engineers medical devices. They include information on medical devices; a designed LED light source is built-in; and endoscopic examinations can be easily performed simply by connecting to a PC for monitoring.
Pregnolia
Series A in 2020
Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, enabling early intervention to prolong gestation and enhance neonatal health outcomes. Pregnolia serves pregnant women and gynecologists, aiming to ensure every woman experiences a happy, healthy, and informed pregnancy. The company's dedicated team, including Sabrina, Francisco, and Annette, is committed to completing clinical trials, navigating regulatory paths, and commercializing the device to support gynecologists in improving preterm birth risk assessment and management.
AVAtronics
Seed Round in 2020
AVAtronics SA is a company based in Lausanne, Switzerland, founded in 2016, that specializes in developing advanced noise-canceling technology for a variety of electronic devices such as headphones, earbuds, hearing aids, and speakerphones. The company has created an Active Noise Cancellation (ANC) solution characterized by low power consumption and wide-band capabilities, allowing it to effectively eliminate unwanted noises while maintaining high-quality audio for music and speech.
Annaida Technologies
Seed Round in 2020
Annaida Technologies SA, founded in 2019 and based in Lausanne, Switzerland, specializes in the development of EmbryoSpin, an innovative device designed for biochemical research. This device performs microscopic nuclear magnetic resonance (µNMR) with a sensitivity that surpasses existing technologies by tenfold, allowing for chemical analysis at the scale of a single human embryo. EmbryoSpin is engineered for robustness and user-friendliness, making it suitable for non-invasive embryo viability screening in in-vitro fertilization and various biochemical studies. The company's advancements aim to enhance medical research capabilities, particularly in the context of reproductive health.
Klepsydra Technologies
Grant in 2020
Klepsydra Technologies GmbH, founded in 2017 and based in Zurich, Switzerland, specializes in software engineering and cloud computing tools for embedded systems. The company provides a lightweight, platform-agnostic software development toolset aimed at facilitating the creation of high-performance applications in sectors such as aerospace, robotics, and smart mobility. Klepsydra's offerings are designed to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks, such as sensor fusion and image processing. By enabling faster and more accessible innovation processes, Klepsydra serves as a valuable resource across various industries, contributing to advancements in autonomous technologies and other computationally intensive applications.
Archilyse
Series A in 2020
Archilyse AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in software for numeric architectural analysis tailored to the real estate sector. The company offers a Software-as-a-Service solution that simplifies the analysis and evaluation of architectural quality through an application programming interface. By converting 2D floor plans and building images into 3D models, Archilyse enables users to conduct various simulations, such as view, geometrical, connectivity, and physical analyses. These simulations provide valuable insights presented in heatmaps or key figure tables, facilitating informed decision-making for portfolio managers, real estate developers, and valuers. Archilyse aims to enhance the real estate lifecycle by leveraging digitization, addressing the information imbalance in the industry, and maximizing benefits for all stakeholders involved.
Nagi Bioscience
Seed Round in 2019
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.
Resistell
Series A in 2019
Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.
Qnami
Seed Round in 2019
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Apiax
Series A in 2019
Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.
Picstars
Venture Round in 2019
Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.